Brain Imaging | XPRT
Articles & Whitepapers
-
Mood enhancement and Neural Network Modulation with Transcutaneous Vagus Nerve Stimulation (tVNS)?
Depression and the vagus nerve Depression affects millions of people worldwide and constitutes a leading cause of disability. Although pharmacological interventions are available, many of them produce suboptimal outcomes due to high non-responsive rates or intolerable side effects. It has been estimated that between 20 to 40 per cent of patients either failed to respond to conventional ...
-
Can We Predict Treatment Success in tVNS?
Predicting Treatment Success Transcutaneous vagus nerve stimulation (tVNS) has recently emerged as a promising treatment for depression and an effective mood enhancer, showing benefits over similar ...
News
-
Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association
Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biopharma company developing cellular therapies for aging-related illnesses, chronic disorders, and other specific life-threatening conditions, announced the publication of results from a Phase 1 ...
